ARQT
Arcutis Biotherapeutics, Inc.$27.16-1.09 (-3.86%)Prev Close$28.26·MCap$3.29B·P/E—·Vol1.07M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
50
$12.59M
◆
Net Activity
Net Seller
$12.59M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Arcutis Biotherapeutics, Inc. (ARQT) has been exclusively selling, with 0 insider purchases totaling $0.00 and 50 insider sales totaling $12.59M. The most recent insider transaction was by Burnett Patrick (officer: EVP, Chief Medical Officer), who sold $30.0K worth of shares on Nov 4, 2026. Arcutis Biotherapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $3.29B.
ARQT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Burnett Patrick | officer: EVP, Chief Medical Officer | Sell | 943 | $31.86 | $30.0K | 116,649 |
| Nov 4, 2026 | Watanabe Todd | director, officer: See Remarks | Sell | 4,377 | $31.86 | $139.5K | 712,826 |
| Nov 4, 2026 | Matsuda Masaru | officer: EVP, Chief Legal Officer | Sell | 41,219 | $34.24 | $1.41M | 111,289-27% |
| Oct 19, 2026 | Welgus Howard G. | director | Sell | 4,728 | $26.93 | $127.3K | 35,207 |
| Sep 18, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 3,674 | $25.00 | $91.9K | 112,508 |
| Sep 17, 2026 | Welgus Howard G. | director | Sell | 4,730 | $24.18 | $114.4K | 35,841 |
| Sep 10, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 9,989 | $25.03 | $250.0K | 116,182 |
| Aug 28, 2026 | Curran Terrie | director | Sell | 27,052 | $25.03 | $677.1K | 23,526-53% |
| Aug 24, 2026 | Curran Terrie | director | Sell | 1,072 | $26.04 | $27.9K | 23,526 |
| Aug 21, 2026 | Burnett Patrick | officer: See Remarks | Sell | 1,697 | $27.00 | $45.8K | 117,592 |
| Aug 19, 2026 | Welgus Howard G. | director | Sell | 4,730 | $26.18 | $123.8K | 36,475 |
| Aug 13, 2026 | Burnett Patrick | officer: See Remarks | Sell | 15,000 | $26.33 | $394.9K | 119,289 |
| Aug 5, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 1,230 | $26.12 | $32.1K | 126,171 |
| Aug 5, 2026 | Watanabe Todd | director, officer: See Remarks | Sell | 4,375 | $26.12 | $114.3K | 717,203 |
| Aug 5, 2026 | Burnett Patrick | officer: See Remarks | Sell | 955 | $26.12 | $24.9K | 119,289 |
| Jul 17, 2026 | Welgus Howard G. | director | Sell | 4,730 | $26.91 | $127.3K | 37,109 |
| Jun 17, 2026 | Welgus Howard G. | director | Sell | 4,731 | $24.58 | $116.3K | 38,378 |
| Jun 17, 2026 | LIN SUE-JEAN | director | Sell | 4,946 | $24.38 | $120.6K | 27,567 |
| May 13, 2026 | Vairavan Latha | officer: SVP Chief Financial Officer | Sell | 435 | $21.05 | $9.2K | 85,978 |
| May 13, 2026 | Burnett Patrick | officer: See Remarks | Sell | 222 | $21.05 | $4.7K | 120,244 |
| May 6, 2026 | Watanabe Todd | director, officer: See Remarks | Sell | 3,172 | $23.61 | $74.9K | 720,755 |
| May 6, 2026 | Burnett Patrick | officer: See Remarks | Sell | 684 | $23.61 | $16.1K | 120,466 |
| May 6, 2026 | Vairavan Latha | officer: SVP Chief Financial Officer | Sell | 1,341 | $23.61 | $31.7K | 86,413 |
| May 6, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 8,256 | $23.31 | $192.4K | 127,573 |
| May 5, 2026 | Welgus Howard G. | director | Sell | 7,144 | $22.99 | $164.2K | 32,600 |
| Apr 3, 2026 | Welgus Howard G. | director | Sell | 10,000 | $23.88 | $238.8K | 39,744 |
| Feb 4, 2026 | Burnett Patrick | officer: See Remarks | Sell | 13,469 | $25.72 | $346.5K | 90,445 |
| Feb 4, 2026 | Edwards Larry Todd | officer: See Remarks | Sell | 2,052 | $25.50 | $52.3K | 148,865 |
| Feb 4, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 7,983 | $25.50 | $203.6K | 142,658 |
| Feb 4, 2026 | Vairavan Latha | officer: SVP Chief Financial Officer | Sell | 1,320 | $25.50 | $33.7K | 63,607 |
| Feb 4, 2026 | Watanabe Todd | director, officer: See Remarks | Sell | 19,833 | $25.50 | $505.7K | 721,306 |
| Feb 4, 2026 | Welgus Howard G. | director | Sell | 10,000 | $25.05 | $250.5K | 59,744 |
| Feb 2, 2026 | Burnett Patrick | See Remarks | Sell | 13,469 | $25.72 | $346.5K | 0 |
| Feb 2, 2026 | Edwards Larry Todd | See Remarks | Sell | 2,052 | $25.50 | $52.3K | 0 |
| Feb 2, 2026 | Matsuda Masaru | See Remarks | Sell | 40,638 | $25.28 | $1.03M | 0 |
| Feb 2, 2026 | Vairavan Latha | SVP Chief Financial Officer | Sell | 1,320 | $25.50 | $33.7K | 0 |
| Feb 2, 2026 | Watanabe Todd | See Remarks | Sell | 19,833 | $25.50 | $505.7K | 0 |
| Feb 2, 2026 | Welgus Howard G. | Director | Sell | 10,000 | $25.05 | $250.5K | 0 |
| Jan 7, 2026 | Burnett Patrick | officer: See Remarks | Sell | 2,490 | $28.98 | $72.2K | 94,120 |
| Jan 6, 2026 | Welgus Howard G. | director | Sell | 10,000 | $28.96 | $289.6K | 69,744 |
| Jan 5, 2026 | Burnett Patrick | See Remarks | Sell | 2,490 | $28.98 | $72.2K | 0 |
| Jan 2, 2026 | Welgus Howard G. | Director | Sell | 10,000 | $28.96 | $289.6K | 0 |
| Dec 31, 2025 | Burnett Patrick | See Remarks | Sell | 1,697 | $29.20 | $49.6K | 0 |
| Dec 15, 2025 | Burnett Patrick | See Remarks | Sell | 11,500 | $28.94 | $332.9K | 0 |
| Dec 1, 2025 | Matsuda Masaru | See Remarks | Sell | 1,657 | $30.23 | $50.1K | 0 |
| Dec 1, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $30.21 | $302.1K | 0 |
| Nov 24, 2025 | LIN SUE-JEAN | Director | Sell | 25,272 | $30.78 | $778.0K | 0 |
| Nov 21, 2025 | Watanabe Todd | See Remarks | Sell | 50,000 | $30.35 | $1.52M | 0 |
| Nov 20, 2025 | Gilbert Halley E | Director | Sell | 16,532 | $27.55 | $455.4K | 0 |
| Nov 19, 2025 | Matsuda Masaru | See Remarks | Sell | 2,550 | $28.29 | $72.1K | 0 |
Showing 1–50 of 235
1 / 5
ARQT Insider Buying Activity
The following table shows recent insider purchases of Arcutis Biotherapeutics, Inc. (ARQT) stock reported via SEC Form 4 filings.
No insider buying activity found for ARQT in the last 12 months.
ARQT Insider Selling Activity
The following table shows recent insider sales of Arcutis Biotherapeutics, Inc. (ARQT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Burnett Patrick | officer: EVP, Chief Medical Officer | Sell | 943 | $31.86 | $30.0K | 116,649 |
| Nov 4, 2026 | Watanabe Todd | director, officer: See Remarks | Sell | 4,377 | $31.86 | $139.5K | 712,826 |
| Nov 4, 2026 | Matsuda Masaru | officer: EVP, Chief Legal Officer | Sell | 41,219 | $34.24 | $1.41M | 111,289-27% |
| Oct 19, 2026 | Welgus Howard G. | director | Sell | 4,728 | $26.93 | $127.3K | 35,207 |
| Sep 18, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 3,674 | $25.00 | $91.9K | 112,508 |
| Sep 17, 2026 | Welgus Howard G. | director | Sell | 4,730 | $24.18 | $114.4K | 35,841 |
| Sep 10, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 9,989 | $25.03 | $250.0K | 116,182 |
| Aug 28, 2026 | Curran Terrie | director | Sell | 27,052 | $25.03 | $677.1K | 23,526-53% |
| Aug 24, 2026 | Curran Terrie | director | Sell | 1,072 | $26.04 | $27.9K | 23,526 |
| Aug 21, 2026 | Burnett Patrick | officer: See Remarks | Sell | 1,697 | $27.00 | $45.8K | 117,592 |
| Aug 19, 2026 | Welgus Howard G. | director | Sell | 4,730 | $26.18 | $123.8K | 36,475 |
| Aug 13, 2026 | Burnett Patrick | officer: See Remarks | Sell | 15,000 | $26.33 | $394.9K | 119,289 |
| Aug 5, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 1,230 | $26.12 | $32.1K | 126,171 |
| Aug 5, 2026 | Watanabe Todd | director, officer: See Remarks | Sell | 4,375 | $26.12 | $114.3K | 717,203 |
| Aug 5, 2026 | Burnett Patrick | officer: See Remarks | Sell | 955 | $26.12 | $24.9K | 119,289 |
| Jul 17, 2026 | Welgus Howard G. | director | Sell | 4,730 | $26.91 | $127.3K | 37,109 |
| Jun 17, 2026 | Welgus Howard G. | director | Sell | 4,731 | $24.58 | $116.3K | 38,378 |
| Jun 17, 2026 | LIN SUE-JEAN | director | Sell | 4,946 | $24.38 | $120.6K | 27,567 |
| May 13, 2026 | Vairavan Latha | officer: SVP Chief Financial Officer | Sell | 435 | $21.05 | $9.2K | 85,978 |
| May 13, 2026 | Burnett Patrick | officer: See Remarks | Sell | 222 | $21.05 | $4.7K | 120,244 |
| May 6, 2026 | Watanabe Todd | director, officer: See Remarks | Sell | 3,172 | $23.61 | $74.9K | 720,755 |
| May 6, 2026 | Burnett Patrick | officer: See Remarks | Sell | 684 | $23.61 | $16.1K | 120,466 |
| May 6, 2026 | Vairavan Latha | officer: SVP Chief Financial Officer | Sell | 1,341 | $23.61 | $31.7K | 86,413 |
| May 6, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 8,256 | $23.31 | $192.4K | 127,573 |
| May 5, 2026 | Welgus Howard G. | director | Sell | 7,144 | $22.99 | $164.2K | 32,600 |
| Apr 3, 2026 | Welgus Howard G. | director | Sell | 10,000 | $23.88 | $238.8K | 39,744 |
| Feb 4, 2026 | Burnett Patrick | officer: See Remarks | Sell | 13,469 | $25.72 | $346.5K | 90,445 |
| Feb 4, 2026 | Edwards Larry Todd | officer: See Remarks | Sell | 2,052 | $25.50 | $52.3K | 148,865 |
| Feb 4, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 7,983 | $25.50 | $203.6K | 142,658 |
| Feb 4, 2026 | Vairavan Latha | officer: SVP Chief Financial Officer | Sell | 1,320 | $25.50 | $33.7K | 63,607 |
| Feb 4, 2026 | Watanabe Todd | director, officer: See Remarks | Sell | 19,833 | $25.50 | $505.7K | 721,306 |
| Feb 4, 2026 | Welgus Howard G. | director | Sell | 10,000 | $25.05 | $250.5K | 59,744 |
| Feb 2, 2026 | Burnett Patrick | See Remarks | Sell | 13,469 | $25.72 | $346.5K | 0 |
| Feb 2, 2026 | Edwards Larry Todd | See Remarks | Sell | 2,052 | $25.50 | $52.3K | 0 |
| Feb 2, 2026 | Matsuda Masaru | See Remarks | Sell | 40,638 | $25.28 | $1.03M | 0 |
| Feb 2, 2026 | Vairavan Latha | SVP Chief Financial Officer | Sell | 1,320 | $25.50 | $33.7K | 0 |
| Feb 2, 2026 | Watanabe Todd | See Remarks | Sell | 19,833 | $25.50 | $505.7K | 0 |
| Feb 2, 2026 | Welgus Howard G. | Director | Sell | 10,000 | $25.05 | $250.5K | 0 |
| Jan 7, 2026 | Burnett Patrick | officer: See Remarks | Sell | 2,490 | $28.98 | $72.2K | 94,120 |
| Jan 6, 2026 | Welgus Howard G. | director | Sell | 10,000 | $28.96 | $289.6K | 69,744 |
| Jan 5, 2026 | Burnett Patrick | See Remarks | Sell | 2,490 | $28.98 | $72.2K | 0 |
| Jan 2, 2026 | Welgus Howard G. | Director | Sell | 10,000 | $28.96 | $289.6K | 0 |
| Dec 31, 2025 | Burnett Patrick | See Remarks | Sell | 1,697 | $29.20 | $49.6K | 0 |
| Dec 15, 2025 | Burnett Patrick | See Remarks | Sell | 11,500 | $28.94 | $332.9K | 0 |
| Dec 1, 2025 | Matsuda Masaru | See Remarks | Sell | 1,657 | $30.23 | $50.1K | 0 |
| Dec 1, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $30.21 | $302.1K | 0 |
| Nov 24, 2025 | LIN SUE-JEAN | Director | Sell | 25,272 | $30.78 | $778.0K | 0 |
| Nov 21, 2025 | Watanabe Todd | See Remarks | Sell | 50,000 | $30.35 | $1.52M | 0 |
| Nov 20, 2025 | Gilbert Halley E | Director | Sell | 16,532 | $27.55 | $455.4K | 0 |
| Nov 19, 2025 | Matsuda Masaru | See Remarks | Sell | 2,550 | $28.29 | $72.1K | 0 |
ARQT Insiders
Similar Stocks to ARQT
VRTX
Vertex Pharmaceuticals Incorporated
$536.14-0.42%
$138.69B
REGN
Regeneron Pharmaceuticals, Inc.
$948.88-0.62%
$99.23B
MRNA
Moderna, Inc.
$214.97-3.55%
$93.61B
RVMD
Revolution Medicines, Inc.
$166.45-3.42%
$39.08B
INSM
Insmed Incorporated
$122.96+1.38%
$26.58B
UTHR
United Therapeutics Corporation
$585.50-0.96%
$25.18B
INCY
Incyte Corporation
$120.12-0.66%
$24.66B
ALNY
Alnylam Pharmaceuticals, Inc.
$159.51-3.31%
$21.41B